China
· Delayed Price · Currency is CNY Shenzhen Kangtai Biological Products Company Description
Shenzhen Kangtai Biological Products Co., Ltd. researches, develops, produces, and sells various types of human vaccines in China.
The company’s products include cell-free whitebait b-type haemophilus influenzae combined vaccine, SARS-COV-2 vaccine, recombinant hepatitis B vaccine, 23-valent pneumococcal polysaccharide vaccine, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccine, haemophilus influenzae type b conjugate vaccine, measles and rubella combined vaccine, 13-valent pneumococcal conjugate vaccine, rabies vaccine, inactivated poliomyelitis vaccine, live attenuated varicella vaccine, and HIB conjugate vaccine.
Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.
| Country | China |
| Founded | 1992 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,902 |
| CEO | Xiang Miao |
Contact Details
Address: No.18, Shutianpu Road Shenzhen, 518107 China | |
| Phone | 86 755 2698 8658 |
| Website | biokangtai.com |
Stock Details
| Ticker Symbol | 300601 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002Q33 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hui Zhou | Chief Financial Officer |
| Xiang Miao | President and Non-Independent Director |
| Jiankai Liu | Vice President and Non-Independent Director |
| Jin Tao | Board Secretary |